Searched for
CROS
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- RBI asks CROs of banks to take pre-emptive measures to mitigate risksThe Reserve Bank of India (RBI) has urged chief compliance officers and Chief Risk Officers (CROs) to take proactive and pre-emptive measur...
- Macroeconomic, geopolitical conditions pose severe risks to organisations: SurveyWith the world facing growing economic instability and political tensions, volatility in geoeconomic and geopolitical relations between maj...
- Two Indian CROs under lens as United States raises data integrity issuesUSFDA's action follows inspections at the facilities of Ahmedabad-based Synchron and Navi Mumbai-based Panexcell, as well as its own analys...
- Genome Valley Research Platform to disrupt the CRO market, aimed at helping young biotech cosGVRP is being launched with a mission to offer a rather unique “plug and play” model for providing drug discovery services to young biotech...
- Capgemini initiates buyout talks with IGate in November: FilingAccording to the sales process detailed by IGate in the filing with the US Securities & Exchange Commission, the first approach was made in...
- Delay in approvals unacceptable: Gujarat CROsAny delay in approvals will be a violation of "Right to Life guaranteed by the Constitution" says Gujarat's CROs.
- Budget 2011: FIEO for extension of weighted deduction to expenditure incurred on clinical trialsFIEO states that removal of the said anomaly will promote in-house R&D in India.
- Global pharma companies' research widens scope for entrepreneursIndia is a favourite clinical trials destination. The CRO business grew 84% during 2006-2008 as against the global average of 12%.
- Tighter norms for clinical research cosThe government will soon make it mandatory for all firms involved in clinical research to maintain minimum quality standards and register t...
- UK cos eye tie-ups to tap $1 bn clinical research marketBritish cos are looking to partner with Indian clinical research organisations (CROs) in a bid to tap the $1 billion (about Rs 4,800 crore)...
- Recession not to hit clinical trials: CROsIndian clinical research organisations do not see any near-term impact of recession as large pharma customers such as AstraZeneca and Glaxo...
- Govt has to create awareness about clinical trials: ExpertsThe multi-million dollar outsourced clinical trial business in India is going through a rough patch, as the Contract Research Organisations...
- Govt may make registration of clinical research cos mandatoryIn a move to step up vigil on clinical research, the government may make it mandatory to register clinical research organisations (CROs) an...
- CROs must play by the bookClinical research organisations (CROs) not adhering to best practices and ethics may now have to deal with stronger regulatory oversight.
- Capgemini plans to move internal support services to IndiaIt is also looking for acquisitions in the US in strategic management consulting and business process outsourcing. BPOs spreading their win...
- Max India eyes control of two CROs in USDelhi-based healthcare and insurance company Max India is looking at acquiring two clinical research organisations (CRO) in the US.
- PPD deal worth $44 m for RanbaxyThe recent in-licensing deal between Indian pharma major Ranbaxy and PPD, a Nasdaq-listed contract research organisation (CRO), could be wo...
Load More
